| ADAMTS6/15 | ADAM metallopeptidase with thrombospondin type 1 motif 6/15 |
| ANGPTL4 | Angiopoietin-like 4 |
| BEC | Blood vascular endothelial cell |
| CDT | Comprehensive decongestive therapy |
| CEMIP2 | Cell migration inducing hyaluronidase 2; also known as: transmembrane protein 2 |
| CHST2 | Carbohydrate sulfotransferase 2 |
| CP | Ceruloplasmin |
| ECM | Extracellular matrix |
| EGLN3 | Egl-9 family hypoxia inducible factor 3 (=PHD3) |
| ELN | Elastin |
| FBLN5 | Fibulin 5 |
| FMOD | Fibromodulin |
| H19 | Long non-coding RNA H19 |
| HA | Hyaluronic acid |
| HD-LEC | Human dermal lymphatic endothelial cells |
| HIF | Hypoxia-inducible factor |
| HMVEC | Human microvascular endothelial cell |
| HTRA3 | HtrA serine peptidase 3 |
| ITIH5 | Inter-alpha-trypsin inhibitor heavy chain family member 5 |
| LE | Lymphedema |
| LEC | Lymphatic endothelial cell |
| lncRNA | Long non-coding RNA |
| LOX | Lysyl-oxidase |
| MMP1 | Matrix metalloproteinase 1 |
| P4HA1 | Prolyl 4-hydroxylase subunit alpha 1 |
| PHD | Prolyl hydroxylase |
| PLOD2 | Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 |
| SLC2A3 | Solute carrier family 2 member 3 (= GLUT3) |
| TGFB1/2/3 | Transforming growth factor-β1/2/3 |
| TNS1 | Tensin-1 |
| TNXB | Tenascin-XB |
| VEGF-A | Vascular endothelial growth factor-A |
| VWA1 | von Willebrand factor A domain containing 1 |